Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SBIR-PhaseII, "Adaptive Goal-Directed Adherence Tracking and Enhancement"

NCT01349985 is registered in ClinicalTrials.gov with Talaria, Inc as lead sponsor.

NCT NCT01349985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SBIR-PhaseII, "Adaptive Goal-Directed Adherence Tracking and Enhancement"
Lead sponsor
Talaria, Inc
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
February 28, 2013
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse